Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide as adjunct therapy to insulin in type 1 diabetes
2012-003580-21Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Liraglutide + insulin with Placebo + insulin (2 arms). Primary endpoint: Change from baseline in HbA1c. Started Mar 2013; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2012-003580-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003580-21.